A24 Signs Distribution Deal With Nordisk Film, First Titles Include ‘Marty Supreme,’ ‘Smashing Machine,’ ‘Warfare’ (EXCLUSIVE)
A24 has signed a deal with Nordic studio and distributor Nordisk Film to release its films across Denmark, Sweden, Norway and ...
Variety2d
A24 Signs Distribution Deal With Nordisk Film, First Titles Include ‘Marty Supreme,’ ‘Smashing Machine,’ ‘Warfare’ (EXCLUSIVE)
A24 has signed a deal with Nordic studio and distributor Nordisk Film to release its films across Denmark, Sweden, Norway and Finland. The first titles covered by the non-exclusive agreement are ...
The New York Times3d
Novo Nordisk Annual Sales Jump on Higher Demand for Obesity Drugs
By Eshe Nelson Reporting from London Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue on Wednesday that ...
Business Insider3d
Novo Nordisk (NVO) Receives a Buy from TD Cowen
In a report released today, Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk (NVO – Research Report). The company’s shares closed yesterday at $82.62. Leverage the ...
Business Insider3d
Novo Nordisk (0QIU) Gets a Buy from Goldman Sachs
In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK875.00. The company’s shares closed ...
Euronews3d
Novo Nordisk shares surge as weight loss treatments boost profits
Europe's largest pharmaceutical firm, Novo Nordisk, reported fourth-quarter earnings that surpassed analysts' expectations. The company’s shares jumped more than 6% at the market open in Europe ...
Reuters4d
Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers
LONDON/SAN FRANCISCO, Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid ...
The Financial Express2d
Novo Nordisk to seek regulatory approval for obesity drug early 2026
The company is also grappling with competition from Eli Lilly. (Image Credits: PIxabay) Novo Nordisk on Wednesday announced that it plan to file its experimental next-generation obesity drug ...
Yahoo Finance5d
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is ...
Wall Street Journal10d
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...